Correction to Merck Earnings Story
04 February 2016 - 8:09AM
Dow Jones News
Combined sales of Type 2 diabetes treatments Januvia and Janumet
declined 12%. "Merck Revenue and Profit Falls -- Update," published
at 12:38 p.m. EST, incorrectly stated that Januvia sales alone
declined 12% in the eighth paragraph. The error also appeared in an
earlier version of the story published at 7:51 a.m. EST
(END) Dow Jones Newswires
February 03, 2016 15:54 ET (20:54 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Merck (NYSE:MRK)
Historical Stock Chart
From Apr 2024 to May 2024
Merck (NYSE:MRK)
Historical Stock Chart
From May 2023 to May 2024